The burden of headache and a health-care needs assessment in the adult population of Mali: a cross-sectional population-based study
Author:
Maiga Youssoufa1, Diallo Seybou H1, Sangho Oumar2, Moskatel Leon Samuel3, Konipo Fatoumata2, Bocoum Abdoulaye1, Diallo Salimata1, Coulibaly Awa1, Daou Mariam1, Dolo Housseini2, Sangaré Modibo2, Albakaye Mohamed1, Traoré Zoumana4, Coulibaly Thomas2, Sissoko Adama2, Landouré Guida2, Guindo Boubacar2, Ahamadou Mahamoudou1, Toure Mahamane Drahamane1, Dembele Abibatou1, Sacko Habib1, Sao Cheick Abdoul Kadri1, Coulibaly Diakalia1, Dembele Salimata1, Coulibaly Cheick Oumar1, Sanogo Mohamadou1, Boiguilé Sekou1, Nizard Julien5, Cowan Robert3, Steiner Timothy J6, Husøy Andreas6
Affiliation:
1. Gabriel Touré Teaching Hospital 2. University of Technical Sciences and Technologies 3. Stanford University 4. Hospital of Mali 5. University of Nantes 6. Norwegian University of Science and Technology (NTNU)
Abstract
Abstract
Background.
Our recent studies have shown headache disorders to be very common in the central and western sub-Saharan countries of Benin and Cameroon. Here we report headache in nearby Mali, a strife-torn country that differs topographically, culturally, politically and economically. The purposes were to estimate headache-attributed burden and need for headache care.
Methods.
We used cluster-random sampling in seven of Mali’s eleven regions to obtain a nationally representative sample. During unannounced household visits by trained interviewers, one randomly selected adult member (18–65 years) from each household was interviewed using the structured HARDSHIP questionnaire, with enquiries into headache in the last year and, additionally, headache yesterday (HY). Headache on ≥ 15 days/month (H15+) was diagnosed as probable medication-overuse headache (pMOH) when associated with acute medication use on ≥ 15 days/month, and as “other H15+” when not. Episodic headache (on < 15 days/month) was recorded as such and not further diagnosed. Burden was assessed as impaired participation (days lost from paid and household work, and from leisure activity). Need for headache care was defined by criteria for expectation of benefit.
Results.
Data collection coincided with the SARS-CoV-2 pandemic. The participating proportion was nonetheless extremely high (99.4%). The observed 1-year prevalence of any headache was 90.9%. Age- and gender-adjusted estimates were 86.3% for episodic headache, 1.4% for pMOH and 3.1% for other H15+. HY was reported by 16.8% with a mean duration of 8.7 hours. Overall mean headache frequency was 3.5 days/month. Participants with pMOH lost more days from paid (8.8 days/3 months) and household work (10.3 days/3 months) than those with other H15+ (3.1 and 2.8 days/3 months) or episodic headache (1.2 and 0.9 days/3 months). At population level, 3.6–5.8% of all time was spent with headache, which led to a 3.6% decrease in all activity (impaired participation). Almost a quarter (23.4%) of Mali’s adult population need headache care.
Conclusion.
Headache is very common in Mali, as in its near neighbours, Benin and Cameroon, and associated with substantial losses of health and productivity. Need for headache care is high – a challenge for a low-income country – but lost productivity probably translates into lost gross domestic product.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Adoukonou T, Agbetou M, Dettin E, Kossi O, Husøy A, Thomas H, Houinato D, Steiner TJ (2004) The prevalence and demographic associations of headache in the adult population of Benin: a cross-sectional population-based study. J Headache Pain 2024; 25: 52 2. Headache in the adult population of Cameroon: prevalence estimates and demographic associations from a cross-sectional nationwide population-based study;Kuate Tegueu C;J Headache Pain,2024 3. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates;Stovner LJ;J Headache Pain,2022 4. Global epidemiology of migraine and its implications for public health and health policy;Steiner TJ;Nat Rev Neurol,2023 5. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Vos T;Lancet,2020
|
|